MicroRNA Expression Profiling of Sputum for the Detection of Early and Locally Advanced Non-Small-Cell Lung Cancer: A Prospective Case–Control Study
Author(s) -
Rene Razzak,
Eric L.R. Bédard,
J.O. Kim,
Sayf Gazala,
Linghong Guo,
Sunita Ghosh,
Anil A. Joy,
Tirath Nijjar,
Eric Wong,
Wilson Roa
Publication year - 2016
Publication title -
current oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.053
H-Index - 51
eISSN - 1718-7729
pISSN - 1198-0052
DOI - 10.3747/co.23.2830
Subject(s) - sputum , lung cancer , medicine , microrna , oncology , stage (stratigraphy) , non small cell lung cancer (nsclc) , adenocarcinoma , confidence interval , cancer , pathology , biology , gene , a549 cell , tuberculosis , paleontology , biochemistry
Non-small-cell lung cancer (nsclc) is associated with very poor overall survival because 70% of patients present with locally advanced or metastatic disease at the time of diagnosis. Micrornas (mirnas) are a class of short, noncoding rna molecules whose presence in samples of biologic fluids such as sputum has demonstrated promise as a potential means of detecting nsclc. We investigated the stage-specific nsclc detection potential of an efficient panel of 3 mirnas (mir-21, mir-210, mir-372) using a single sputum sample.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom